Prognostic significance of cytokine levels in newly-diagnosed AML and high-risk myelodysplasia.

被引：0
|
作者：
Albitar, M [1 ]
Estey, E [1 ]
Doherty, D [1 ]
Shen, Y [1 ]
Cortes, J [1 ]
O'Brien, S [1 ]
Giles, F [1 ]
Kantarjian, H [1 ]
Kurzrock, R [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1382
引用
收藏
页码：327A / 327A
页数：1
相关论文
共 50 条
  • [31] DIRECT RELATIONSHIP OF REMISSION DURATION TO POST CHEMOTHERAPY TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN 55 NEWLY-DIAGNOSED HIGH-RISK ACUTE MYELOID-LEUKEMIA (AML) PATIENTS
    SHETTY, V
    KOCHUPILLAI, V
    SAIKIA, T
    GREGORY, S
    LOEW, J
    ALVI, S
    LARSON, R
    GOLDBERG, J
    SHOTT, S
    PREISLER, H
    RAZA, A
    BLOOD, 1994, 84 (10) : A625 - A625
  • [32] Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
    M Binder
    S V Rajkumar
    R P Ketterling
    P T Greipp
    A Dispenzieri
    M Q Lacy
    M A Gertz
    F K Buadi
    S R Hayman
    Y L Hwa
    S R Zeldenrust
    J A Lust
    S J Russell
    N Leung
    P Kapoor
    R S Go
    W I Gonsalves
    R A Kyle
    S K Kumar
    Blood Cancer Journal, 2017, 7 : e600 - e600
  • [33] Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
    Binder, M.
    Rajkumar, S. V.
    Ketterling, R. P.
    Greipp, P. T.
    Dispenzieri, A.
    Lacy, M. Q.
    Gertz, M. A.
    Buadi, F. K.
    Hayman, S. R.
    Hwa, Y. L.
    Zeldenrust, S. R.
    Lust, J. A.
    Russell, S. J.
    Leung, N.
    Kapoor, P.
    Go, R. S.
    Gonsalves, W. I.
    Kyle, R. A.
    Kumar, S. K.
    BLOOD CANCER JOURNAL, 2017, 7 : e600 - e600
  • [34] Prognostic Significance of Weight Loss and BMI during Induction Chemotherapy of Newly Diagnosed Acute Myeloid Leukemia (AML) Patients
    Smith, Zachary
    Vidal, Gabriel
    Machiorlatti, Michael
    Vesely, Sara K.
    Frank, Summer
    Asch, Adam S.
    Holter-Chakrabarty, Jennifer L.
    Khawandanah, Mohamad
    Cherry, Mohamad
    BLOOD, 2015, 126 (23)
  • [35] Expanding the High-Risk Definition for Children with Newly Diagnosed Acute Myeloid Leukemia
    Lamble, Adam J.
    Ries, Rhonda E.
    Alonzo, Todd A.
    Wang, Yi-Cheng
    Farrar, Jason E.
    Huang, Benjamin J.
    Kutny, Matthew A.
    Pollard, Jessica A.
    Aplenc, Richard
    Gamis, Alan S.
    Kolb, Edward A.
    Cooper, Todd M.
    Meshinchi, Soheil
    BLOOD, 2022, 140 : 3393 - 3394
  • [36] Caution With Routine Use of Daratumumab for Newly Diagnosed High-Risk Multiple Myeloma
    Mohyuddin, Ghulam Rehman
    Abdallah, Al-Ola
    McClune, Brian
    JAMA ONCOLOGY, 2021, 7 (04) : 635 - 635
  • [37] Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple Myeloma
    Naimisha Marneni
    Rajshekhar Chakraborty
    Current Hematologic Malignancy Reports, 2021, 16 : 148 - 161
  • [38] Analysis of High-Risk Extramedullary Relapse Factors in Newly Diagnosed MM Patients
    Yue, Xiaoyan
    He, Donghua
    Zheng, Gaofeng
    Yang, Yang
    Han, Xiaoyan
    Li, Yi
    Zhao, Yi
    Wu, Wenjun
    Chen, Qingxiao
    Zhang, Enfang
    Cai, Zhen
    He, Jingsong
    CANCERS, 2022, 14 (24)
  • [39] Roundtable: How I treat a newly diagnosed patient with high-risk myeloma
    Kaufman, Jonathan L.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 120 - 124
  • [40] Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple Myeloma
    Marneni, Naimisha
    Chakraborty, Rajshekhar
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (02) : 148 - 161
12345